EDISON, N.J.--(BUSINESS WIRE)--I-many, Inc. (NASDAQ:IMNY), a leading provider of contract management software and services for the enterprise, today announced a top five global generics pharmaceutical company has licensed I-many’s recently introduced I-many CARS® NG solution. This industry-leading company is yet another new customer for I-many since I-many CARS NG was introduced on June 20th of this year. This now brings the total of major pharmaceutical companies who have licensed one or more of I-many’s new generation solutions to 26, which includes 16 generic companies committed to I-many solutions.